Rabies Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 60 pages | ID: R7E80E6210F9EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Rabies Treatment in Global, including the following market information:

Global Rabies Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Rabies Treatment market was valued at 4271.7 million in 2021 and is projected to reach US$ 5201 million by 2028, at a CAGR of 2.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Cell Culture Vaccines (CCVs) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Rabies Treatment include Cadila Healthcare, GlaxoSmithKline, Merial, Sanofi, Merck, Pfizer, Bayer, AstraZeneca and Amneal Pharmaceuticals and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rabies Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Rabies Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Rabies Treatment Market Segment Percentages, by Type, 2021 (%)

• Cell Culture Vaccines (CCVs)
• Rabies Immunoglobulin (RIGs)
• Nerve Tissue Vaccines (NTVs)

Global Rabies Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Rabies Treatment Market Segment Percentages, by Application, 2021 (%)

• Pre-exposure Prophylaxis
• Post-exposure Prophylaxis

Global Rabies Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Rabies Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Rabies Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Rabies Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Cadila Healthcare
• GlaxoSmithKline
• Merial
• Sanofi
• Merck
• Pfizer
• Bayer
• AstraZeneca
• Amneal Pharmaceuticals
• Anergis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Rabies Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Rabies Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RABIES TREATMENT OVERALL MARKET SIZE

2.1 Global Rabies Treatment Market Size: 2021 VS 2028
2.2 Global Rabies Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Rabies Treatment Players in Global Market
3.2 Top Global Rabies Treatment Companies Ranked by Revenue
3.3 Global Rabies Treatment Revenue by Companies
3.4 Top 3 and Top 5 Rabies Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Rabies Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Rabies Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Rabies Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Rabies Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Rabies Treatment Market Size Markets, 2021 & 2028
  4.1.2 Cell Culture Vaccines (CCVs)
  4.1.3 Rabies Immunoglobulin (RIGs)
  4.1.4 Nerve Tissue Vaccines (NTVs)
4.2 By Type - Global Rabies Treatment Revenue & Forecasts
  4.2.1 By Type - Global Rabies Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Rabies Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Rabies Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Rabies Treatment Market Size, 2021 & 2028
  5.1.2 Pre-exposure Prophylaxis
  5.1.3 Post-exposure Prophylaxis
5.2 By Application - Global Rabies Treatment Revenue & Forecasts
  5.2.1 By Application - Global Rabies Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Rabies Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Rabies Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Rabies Treatment Market Size, 2021 & 2028
6.2 By Region - Global Rabies Treatment Revenue & Forecasts
  6.2.1 By Region - Global Rabies Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Rabies Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Rabies Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Rabies Treatment Revenue, 2017-2028
  6.3.2 US Rabies Treatment Market Size, 2017-2028
  6.3.3 Canada Rabies Treatment Market Size, 2017-2028
  6.3.4 Mexico Rabies Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Rabies Treatment Revenue, 2017-2028
  6.4.2 Germany Rabies Treatment Market Size, 2017-2028
  6.4.3 France Rabies Treatment Market Size, 2017-2028
  6.4.4 U.K. Rabies Treatment Market Size, 2017-2028
  6.4.5 Italy Rabies Treatment Market Size, 2017-2028
  6.4.6 Russia Rabies Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Rabies Treatment Market Size, 2017-2028
  6.4.8 Benelux Rabies Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Rabies Treatment Revenue, 2017-2028
  6.5.2 China Rabies Treatment Market Size, 2017-2028
  6.5.3 Japan Rabies Treatment Market Size, 2017-2028
  6.5.4 South Korea Rabies Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Rabies Treatment Market Size, 2017-2028
  6.5.6 India Rabies Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Rabies Treatment Revenue, 2017-2028
  6.6.2 Brazil Rabies Treatment Market Size, 2017-2028
  6.6.3 Argentina Rabies Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Rabies Treatment Revenue, 2017-2028
  6.7.2 Turkey Rabies Treatment Market Size, 2017-2028
  6.7.3 Israel Rabies Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Rabies Treatment Market Size, 2017-2028
  6.7.5 UAE Rabies Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Cadila Healthcare
  7.1.1 Cadila Healthcare Corporate Summary
  7.1.2 Cadila Healthcare Business Overview
  7.1.3 Cadila Healthcare Rabies Treatment Major Product Offerings
  7.1.4 Cadila Healthcare Rabies Treatment Revenue in Global Market (2017-2022)
  7.1.5 Cadila Healthcare Key News
7.2 GlaxoSmithKline
  7.2.1 GlaxoSmithKline Corporate Summary
  7.2.2 GlaxoSmithKline Business Overview
  7.2.3 GlaxoSmithKline Rabies Treatment Major Product Offerings
  7.2.4 GlaxoSmithKline Rabies Treatment Revenue in Global Market (2017-2022)
  7.2.5 GlaxoSmithKline Key News
7.3 Merial
  7.3.1 Merial Corporate Summary
  7.3.2 Merial Business Overview
  7.3.3 Merial Rabies Treatment Major Product Offerings
  7.3.4 Merial Rabies Treatment Revenue in Global Market (2017-2022)
  7.3.5 Merial Key News
7.4 Sanofi
  7.4.1 Sanofi Corporate Summary
  7.4.2 Sanofi Business Overview
  7.4.3 Sanofi Rabies Treatment Major Product Offerings
  7.4.4 Sanofi Rabies Treatment Revenue in Global Market (2017-2022)
  7.4.5 Sanofi Key News
7.5 Merck
  7.5.1 Merck Corporate Summary
  7.5.2 Merck Business Overview
  7.5.3 Merck Rabies Treatment Major Product Offerings
  7.5.4 Merck Rabies Treatment Revenue in Global Market (2017-2022)
  7.5.5 Merck Key News
7.6 Pfizer
  7.6.1 Pfizer Corporate Summary
  7.6.2 Pfizer Business Overview
  7.6.3 Pfizer Rabies Treatment Major Product Offerings
  7.6.4 Pfizer Rabies Treatment Revenue in Global Market (2017-2022)
  7.6.5 Pfizer Key News
7.7 Bayer
  7.7.1 Bayer Corporate Summary
  7.7.2 Bayer Business Overview
  7.7.3 Bayer Rabies Treatment Major Product Offerings
  7.7.4 Bayer Rabies Treatment Revenue in Global Market (2017-2022)
  7.7.5 Bayer Key News
7.8 AstraZeneca
  7.8.1 AstraZeneca Corporate Summary
  7.8.2 AstraZeneca Business Overview
  7.8.3 AstraZeneca Rabies Treatment Major Product Offerings
  7.8.4 AstraZeneca Rabies Treatment Revenue in Global Market (2017-2022)
  7.8.5 AstraZeneca Key News
7.9 Amneal Pharmaceuticals
  7.9.1 Amneal Pharmaceuticals Corporate Summary
  7.9.2 Amneal Pharmaceuticals Business Overview
  7.9.3 Amneal Pharmaceuticals Rabies Treatment Major Product Offerings
  7.9.4 Amneal Pharmaceuticals Rabies Treatment Revenue in Global Market (2017-2022)
  7.9.5 Amneal Pharmaceuticals Key News
7.10 Anergis
  7.10.1 Anergis Corporate Summary
  7.10.2 Anergis Business Overview
  7.10.3 Anergis Rabies Treatment Major Product Offerings
  7.10.4 Anergis Rabies Treatment Revenue in Global Market (2017-2022)
  7.10.5 Anergis Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Rabies Treatment Market Opportunities & Trends in Global Market
Table 2. Rabies Treatment Market Drivers in Global Market
Table 3. Rabies Treatment Market Restraints in Global Market
Table 4. Key Players of Rabies Treatment in Global Market
Table 5. Top Rabies Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Rabies Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Rabies Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Rabies Treatment Product Type
Table 9. List of Global Tier 1 Rabies Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rabies Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Rabies Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Rabies Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Rabies Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Rabies Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Rabies Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Rabies Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Rabies Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Rabies Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Rabies Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Rabies Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Rabies Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Rabies Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Rabies Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Rabies Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Rabies Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Rabies Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Rabies Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Rabies Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Rabies Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Cadila Healthcare Corporate Summary
Table 31. Cadila Healthcare Rabies Treatment Product Offerings
Table 32. Cadila Healthcare Rabies Treatment Revenue (US$, Mn), (2017-2022)
Table 33. GlaxoSmithKline Corporate Summary
Table 34. GlaxoSmithKline Rabies Treatment Product Offerings
Table 35. GlaxoSmithKline Rabies Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Merial Corporate Summary
Table 37. Merial Rabies Treatment Product Offerings
Table 38. Merial Rabies Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Sanofi Corporate Summary
Table 40. Sanofi Rabies Treatment Product Offerings
Table 41. Sanofi Rabies Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Merck Corporate Summary
Table 43. Merck Rabies Treatment Product Offerings
Table 44. Merck Rabies Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer Rabies Treatment Product Offerings
Table 47. Pfizer Rabies Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Bayer Corporate Summary
Table 49. Bayer Rabies Treatment Product Offerings
Table 50. Bayer Rabies Treatment Revenue (US$, Mn), (2017-2022)
Table 51. AstraZeneca Corporate Summary
Table 52. AstraZeneca Rabies Treatment Product Offerings
Table 53. AstraZeneca Rabies Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Amneal Pharmaceuticals Corporate Summary
Table 55. Amneal Pharmaceuticals Rabies Treatment Product Offerings
Table 56. Amneal Pharmaceuticals Rabies Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Anergis Corporate Summary
Table 58. Anergis Rabies Treatment Product Offerings
Table 59. Anergis Rabies Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Rabies Treatment Segment by Type in 2021
Figure 2. Rabies Treatment Segment by Application in 2021
Figure 3. Global Rabies Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Rabies Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Rabies Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Rabies Treatment Revenue in 2021
Figure 8. By Type - Global Rabies Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Rabies Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Rabies Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Rabies Treatment Revenue Market Share, 2017-2028
Figure 12. US Rabies Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Rabies Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Rabies Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Rabies Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Rabies Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Rabies Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Rabies Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Rabies Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Rabies Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Rabies Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Rabies Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Rabies Treatment Revenue Market Share, 2017-2028
Figure 24. China Rabies Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Rabies Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Rabies Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Rabies Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Rabies Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Rabies Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Rabies Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Rabies Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Rabies Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Rabies Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Rabies Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Rabies Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Rabies Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Cadila Healthcare Rabies Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GlaxoSmithKline Rabies Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merial Rabies Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sanofi Rabies Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck Rabies Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer Rabies Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bayer Rabies Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. AstraZeneca Rabies Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Amneal Pharmaceuticals Rabies Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Anergis Rabies Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)